Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Discover which indices swing the most and how those swings translate into trading opportunities, with practical tips to gauge momentum.
24,519 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
Anthropic’s spacex compute deal expands access to the Colossus supercomputer, boosting Claude capacity while triggeri...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
This in-depth look at Ideal Power's Q1 2026 earnings breaks down the numbers, the growth drivers, and what it means f...
Cerebras Systems jumped after its IPO, but is it too late to join the rally? This guide breaks down the tech, market ...
Shoe Carnival's 2025 earnings season offers clues about margins, online growth, and store results. This guide breaks ...
This deep dive breaks down NextPlat's Q1 2026 earnings, translating the numbers into practical takeaways for investor...
Realtor.com launches AGOYU AI-powered moving quotes, letting users generate real-time estimates from video without in...
When a high-profile IPO opens its doors to everyday traders, the landscape for retail investors changes. This guide e...
Microsoft stock sinking today has investors looking past a single bad headline. This deep-dive explains the drivers b...
Chewy has shown growth in revenue alongside margin pressures as it scales its e-commerce pet-products platform. This ...